363 related articles for article (PubMed ID: 35011682)
1. Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy-An Integrated View into Other Neoplasms and Chemokine Networks.
Filimon A; Preda IA; Boloca AF; Negroiu G
Cells; 2021 Dec; 11(1):. PubMed ID: 35011682
[TBL] [Abstract][Full Text] [Related]
2. Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.
Jacquelot N; Duong CPM; Belz GT; Zitvogel L
Front Immunol; 2018; 9():2480. PubMed ID: 30420855
[TBL] [Abstract][Full Text] [Related]
3. IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.
Mattei F; Schiavoni G; Sestili P; Spadaro F; Fragale A; Sistigu A; Lucarini V; Spada M; Sanchez M; Scala S; Battistini A; Belardelli F; Gabriele L
Neoplasia; 2012 Dec; 14(12):1223-35. PubMed ID: 23308054
[TBL] [Abstract][Full Text] [Related]
4. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
[TBL] [Abstract][Full Text] [Related]
5. CXCL8 and its cognate receptors in melanoma progression and metastasis.
Singh S; Singh AP; Sharma B; Owen LB; Singh RK
Future Oncol; 2010 Jan; 6(1):111-6. PubMed ID: 20021212
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma.
Varney ML; Johansson SL; Singh RK
Am J Clin Pathol; 2006 Feb; 125(2):209-16. PubMed ID: 16393674
[TBL] [Abstract][Full Text] [Related]
7. An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.
Mishra A; Suman KH; Nair N; Majeed J; Tripathi V
Mol Biol Rep; 2021 Sep; 48(9):6551-6561. PubMed ID: 34426905
[TBL] [Abstract][Full Text] [Related]
8. Chemokines as possible therapeutic targets in metastatic melanoma.
Basson C; Serem JC; Bipath P; Hlophe YN
Cancer Med; 2023 Jul; 12(13):14387-14402. PubMed ID: 37170733
[TBL] [Abstract][Full Text] [Related]
9. CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
Sapoznik S; Ortenberg R; Galore-Haskel G; Kozlovski S; Levy D; Avivi C; Barshack I; Cohen CJ; Besser MJ; Schachter J; Markel G
Cancer Immunol Immunother; 2012 Oct; 61(10):1833-47. PubMed ID: 22441657
[TBL] [Abstract][Full Text] [Related]
10. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
Kemp DM; Pidich A; Larijani M; Jonas R; Lash E; Sato T; Terai M; De Pizzol M; Allegretti M; Igoucheva O; Alexeev V
Oncotarget; 2017 Feb; 8(9):14428-14442. PubMed ID: 28129639
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model.
Gabellini C; Gómez-Abenza E; Ibáñez-Molero S; Tupone MG; Pérez-Oliva AB; de Oliveira S; Del Bufalo D; Mulero V
Int J Cancer; 2018 Feb; 142(3):584-596. PubMed ID: 28949016
[TBL] [Abstract][Full Text] [Related]
12. Expression of chemokine receptors by subsets of neurons in the central nervous system.
Horuk R; Martin AW; Wang Z; Schweitzer L; Gerassimides A; Guo H; Lu Z; Hesselgesser J; Perez HD; Kim J; Parker J; Hadley TJ; Peiper SC
J Immunol; 1997 Mar; 158(6):2882-90. PubMed ID: 9058825
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
14. The good and the bad of chemokines/chemokine receptors in melanoma.
Richmond A; Yang J; Su Y
Pigment Cell Melanoma Res; 2009 Apr; 22(2):175-86. PubMed ID: 19222802
[TBL] [Abstract][Full Text] [Related]
15. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.
Varney ML; Li A; Dave BJ; Bucana CD; Johansson SL; Singh RK
Clin Exp Metastasis; 2003; 20(8):723-31. PubMed ID: 14713106
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
Kline M; Donovan K; Wellik L; Lust C; Jin W; Moon-Tasson L; Xiong Y; Witzig TE; Kumar S; Rajkumar SV; Lust JA
Leuk Res; 2007 May; 31(5):591-8. PubMed ID: 16879867
[TBL] [Abstract][Full Text] [Related]
17. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
18. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.
Sharma I; Singh A; Siraj F; Saxena S
J Biomed Sci; 2018 Aug; 25(1):62. PubMed ID: 30086759
[TBL] [Abstract][Full Text] [Related]
19. CD82/KAI expression prevents IL-8-mediated endothelial gap formation in late-stage melanomas.
Khanna P; Chung CY; Neves RI; Robertson GP; Dong C
Oncogene; 2014 May; 33(22):2898-908. PubMed ID: 23873025
[TBL] [Abstract][Full Text] [Related]
20. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness.
Kunz M; Hartmann A; Flory E; Toksoy A; Koczan D; Thiesen HJ; Mukaida N; Neumann M; Rapp UR; Bröcker EB; Gillitzer R
Am J Pathol; 1999 Sep; 155(3):753-63. PubMed ID: 10487833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
